Cindy Tahl insider trades: Fate Therapeutics (FATE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cindy reports to the SEC
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | FATE | ↓ Sell | 38,800 | $2.46 | $95K | Direct | Aug 5, 2026 (1d) |
| May 20, 2026 | FATE | ↓ Sell | 25,590 | $1.88 | $48K | Direct | May 21, 2026 (1d) |
| Jan 9, 2026 | FATE | ↓ Sell | 10,589 | $1.06 | $11K | Direct | Jan 12, 2026 (3d) |
| Aug 4, 2025 | FATE | ↓ Sell | 9,037 | $1.06 | $10K | Direct | Aug 5, 2025 (1d) |
| Jan 10, 2025 | FATE | ↓ Sell | 5,654 | $1.55 | $9K | Direct | Jan 13, 2025 (3d) |
| Jan 9, 2024 | FATE | ↓ Sell | 10,874 | $4.37 | $48K | Direct | Jan 10, 2024 (1d) |
| Nov 9, 2023 | FATE | ↓ Sell | 24,363 | $2.40 | $58K | Direct | Nov 13, 2023 (4d) |
| Jan 10, 2023 | FATE | ↓ Sell | 11,553 | $5.24 | $61K | Direct | Jan 11, 2023 (1d) |
| Jun 1, 2022 | FATE | ↓ Sell | 25,000 | $22.96 | $574K | Direct | Jun 2, 2022 (1d) |
| Apr 1, 2022 | FATE | ↓ Sell | 25,000 | $38.85 | $971K | Direct | Apr 4, 2022 (3d) |
| Jan 11, 2022 | FATE | ↓ Sell | 5,419 | $48.53 | $263K | Direct | Jan 13, 2022 (2d) |
| Jan 10, 2022 | FATE | ↓ Sell | 7,738 | $46.43 | $359K | Direct | Jan 12, 2022 (2d) |
| Jan 3, 2022 | FATE | ↓ Sell | 50,000 | $59.34 | $3.0M | Direct | Jan 4, 2022 (1d) |
| Oct 1, 2021 | FATE | ↓ Sell | 50,000 | $58.83 | $2.9M | Direct | Oct 4, 2021 (3d) |
| Jul 1, 2021 | FATE | ↓ Sell | 55,534 | $85.24 | $4.7M | Direct | Jul 2, 2021 (1d) |
| Apr 1, 2021 | FATE | ↓ Sell | 30,000 | $83.81 | $2.5M | Direct | Apr 2, 2021 (1d) |
| Jan 19, 2021 | FATE | ↓ Sell | 35,000 | $114.76 | $4.0M | Direct | Jan 21, 2021 (2d) |
| Jan 11, 2021 | FATE | ↓ Sell | 9,483 | $114.94 | $1.1M | Direct | Jan 12, 2021 (1d) |
| Nov 5, 2020 | FATE | ↓ Sell | 70,801 | $50.47 | $3.6M | Direct | Nov 6, 2020 (1d) |
| Oct 16, 2020 | FATE | ↓ Sell | 29,199 | $50.25 | $1.5M | Direct | Oct 20, 2020 (4d) |
| Oct 1, 2020 | FATE | ↓ Sell | 35,000 | $40.74 | $1.4M | Direct | Oct 2, 2020 (1d) |
| Jan 8, 2020 | FATE | ↓ Sell | 5,700 | $20.72 | $118K | Direct | Jan 10, 2020 (2d) |
| Oct 15, 2019 | FATE | ↓ Sell | 10,200 | $14.24 | $145K | Direct | Oct 16, 2019 (1d) |
| Mar 1, 2019 | FATE | ↓ Sell | 25,000 | $16.15 | $404K | Direct | Mar 5, 2019 (4d) |
| Feb 25, 2019 | FATE | ↓ Sell | 25,000 | $16.07 | $402K | Direct | Feb 27, 2019 (2d) |
| Jan 7, 2019 | FATE | ↓ Sell | 25,000 | $16.00 | $400K | Direct | Jan 9, 2019 (2d) |
| Oct 16, 2017 | FATE | ↓ Sell | 8,091 | $3.85 | $31K | Direct | Oct 17, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FATE insiders
Open-market trades in the last 12 months
About Cindy Tahl's insider trades
Cindy Tahl is See Remarks at Fate Therapeutics (FATE). Since Oct 16, 2017, Cindy has reported no open-market purchases and 27 sales worth $28.7M on SEC Form 4. In the last 12 months: 3 sales ($155K).
Their filings also include option exercises (14 filings), grants and awards (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FATE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.